NCT06172946Completed
Effect of Powerbreath Versus Transcutaneous Electrical Diaphragmatic Stimulation on The Severity of Copd
Effect of Inspiratory Muscle Training Versus Transcutaneous Electrical Diaphragmatic Stimulation on The Severity of Copd
Source: ClinicalTrials.gov · Last updated 18 Feb 2025
Brief summary (registry, in English)
Chronic obstructive pulmonary disease (COPD) is a common and treatable disease characterized by progressive airflow limitation and tissue destruction. It is associated with structural lung changes due to chronic inflammation from prolonged exposure to noxious particles or gases most commonly cigarette smoke. POWERbreathe device (POWER-breathe International Ltd., Southam, Warwickshire, UK) is an inspiratory muscle training and this device has recently shown benefits on pulmonary function. Also, the POWER-breathe® device's effects on the strength of the diaphragm muscle and minimize muscle weakness and wasting in COPD patients. Neuromuscular electrical stimulation (NMES) is commonly used in physical therapy to increase muscle strength and promote muscle hypertrophy. NMES applied to respiratory rehabilitation is called transcutaneous electrical diaphragmatic stimulation (TEDS).
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 60 (actual)
- First submitted
- 3 Dec 2023
- Start date
- 12 Dec 2023
- Primary completion date
- 25 Mar 2024
- Lead sponsor
- Cairo University
- Diseases
- COPD
- NCT number
- NCT06172946
What you commit to
- Study type: Interventional
- Participants enrolled: 60
- From 12 Dec 2023 to the primary completion date, 25 Mar 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with the following criteria will be excluded from the study:
- Lack of language or cognitive abilities to fill out questionnaire.
- Patients with cardiac pacemaker.
- Contraindications for inspiratory muscle training (e.g. a history of recent lung surgery, recent pulmonary embolism, history of recurrent spontaneous pneumothorax, other serious lung disease).
- Existing arterial aneurysm.
- Clinical signs of unstable cardiac event (eg. congestive heart failure).
- Patients with malignant disease.
- Acute COPD exacerbation within the last 4 weeks.
- Any need for supplemental oxygen.
- Patients with Gastro-esophageal reflux disease.
- Patients with active Hemoptysis.
Who the study is looking for
- The patient selection will be according to the following criteria:
- Male patients diagnosed with stage 2\&3 COPD.
- All patients are under full medical control.
- Their ages will range from forty-five to sixty-five years.
- Patients with BMI from 25-29.9 kg/m2
Age in the registry: 45 years to 65 years · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Cairo University Coordinator of this site? Confirm its status | Cairo | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.